Voltage-gated K ϩ (Kv) channels play critical roles in a wide variety of physiological processes, including the regulation of neurotransmitter release, neuronal excitability, heart rate, muscle contraction, hormone secretion, epithelial electrolyte transport, cell volume, and cell proliferation in neuronal and non-neuronal cells.
The Kva subunit is composed of six a-helical transmembrane segments (S1-S6). The S4 segment acts as the voltage-sensing apparatus of the K ϩ channel, 1) while the poreforming S5-S6 segments constitute a selectivity filter and govern voltage-dependent increases in K ϩ permeability. Sitedirected mutagenesis studies using Kva subunits have clarified the detailed action and binding sites of various drugs that regulate Kv channel activity. 1) Some Kv channel a subunits exhibit transient A-type K ϩ currents and N-type inactivation.
2) For example, Kv1.4 channels are one of the families of voltage-gated K ϩ channels that mediate rapidly inactivating A-type currents and N-type inactivation. The molecular mechanism of this channel inactivation is thought to be of the N-type; i.e., a "ball" domain within the N-terminal polypeptide structure can occlude the channel from inside, thus blocking current flow. Thus, N-terminal deletions remove inactivation and induce non-inactivating persistent outward K ϩ currents and C-type inactivation. [3] [4] [5] Recently, we reported that ginsenoside Rg 3 (20-S-protopanaxadiol-3-[O-b-D-glucopyranosyl (1→2)-b-glucopyranoside]) (Rg 3 ) inhibits voltage-dependent transient human Kv1.4 (hKv1.4) channel currents by forming hydrogen bonds between Rg 3 and amino acids, including K531 residue of the channels, using the site-directed mutagenesis method. 6) In this report, we present evidence that Rg 3 inhibits preferentially non-inactivating persistent rather than peak outward currents in N-terminal (D2-61) deleted hKv1.4 (hKv1.4D2-61) channels. In addition, mutation of K531 hKv1.4D2-61 to K531Y hKv1.4D2-61 and raising the extracellular [K ϩ ] abolished the inhibitory effect of Rg 3 on non-inactivating plateau outward currents. Rg 3 increases the C-type inactivation rate, but raising the extracellular [K ϩ ] o reverses Rg 3 action on hKv1.4D2-61 channels. These results support that K531 residue also plays an important role in the Rg 3 -mediated noninactivating current blockage of hKv1.4D2-61 channels. Figure 1 shows the chemical structure of ginsenoside Rg 3 (20- vided by Dr. Pongs (University of Hamburg, Germany). Other agents were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.).
MATERIALS AND METHODS

Materials
Preparation of Xenopus Oocytes and Microinjection Xenopus laevis frogs were purchased from Xenopus I (Ann Arbor, MI, U.S.A.). Their care and handling were in accordance with the highest standards of institutional guidelines. For isolation of oocytes, frogs were anesthetized with an aerated solution of 3-amino benzoic acid ethyl ester, and the ovarian follicles were removed. The oocytes were separated with collagenase followed by agitation for 2 h in Ca 2ϩ -free medium containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, 2.5 mM sodium pyruvate, 100 units/ml penicillin and 100 mg/ml streptomycin. Stage V-VI oocytes were collected and stored in ND96 medium (in mM: 96 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 , and 5 HEPES, pH 7.5) supplemented with 0.5 mM theophylline and 50 mg/ml gentamicin. The oocyte-containing solution was maintained at 18°C with continuous gentle shaking and renewed every day. Electrophysiological experiments were performed within 5-6 d of oocyte isolation, with chemicals applied to the bath. For K ϩ channel experiments, Kv channel-encoding cRNAs (40 nl) were injected into the animal or vegetal pole of each oocyte 1 d after isolation, using a 10 ml microdispenser (VWR Scientific, San Francisco, CA, U.S.A.) fitted with a tapered glass pipette tip (15-20 mm in diameter).
7)
Site-Directed Mutagenesis of the Kv1.4 a a Subunit and in Vitro Transcription of Kv1.4 Channel cDNAs Single or double amino acid substitutions were made using a QuikChange TM XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, U.S.A.), along with Pfu DNA polymerase and sense and antisense primers encoding the desired mutations. Overlap extension of the target domain by sequential polymerase chain reaction (PCR) was carried out according to the manufacturer's protocol. The final PCR products were transformed into Escherichia coli strain DH5a, screened by PCR and confirmed by sequencing of the target regions. The mutant DNA constructs were linearized at their 3Ј ends by digestion with XhoI, and run-off transcripts were prepared using the methylated cap analog, m 7 G(5Ј)ppp(5Ј)G. The cRNAs were prepared using a mMessage mMachine transcription kit (Ambion, Austin, TX, U.S.A.) with T7 RNA polymerase. The absence of degraded RNA was confirmed by denaturing agarose gel electrophoresis followed by ethidium bromide staining. Similarly, recombinant plasmids containing Kv channel cDNA inserts were linearized by digestion with the appropriate restriction enzymes, and cRNAs were obtained using the mMessage mMachine in vitro transcription kit with SP6 RNA polymerase or T7 polymerase. The final cRNA products were resuspended at a concentration of 1 mg/ml in RNase-free water and stored at Ϫ80°C.
6)
Data Recording A custom-made Plexiglas net chamber was used for two-electrode voltage-clamp recordings as previously reported.
6) The oocytes were impaled with two microelectrodes filled with 3 M KCl (0.2-0.7 MW), and electrophysiological experiments were carried out at room temperature using an Oocyte Clamp (OC-725C, Warner Instruments, Hamsden, CT, U.S.A.). Stimulation and data acquisition were controlled with a pClamp 8 (Axon Instruments, Union City, CA, U.S.A.). For most electrophysiological experiments, oocytes were perfused initially with ND96 solution (in mM: 96 NaCl, 3 KCl, 2 CaCl 2 , 5 HEPES, pH 7.4 with NaOH), and control current recordings were obtained. To measure K ϩ activation of the Kv1.4 channel, a solution was applied in which the NaCl was replaced with various concentrations of KCl. In all cases, the solution was perfused at a flow rate of ca. 3 ml/min, and the system was allowed 30 to 60 s to reach steady state prior to current recording. The oocytes were then clamped at a holding potential of Ϫ80 mV, membrane potential was depolarized to ϩ50 mV for 500 ms every 10 s, and currents were recorded.
Data Analysis To obtain the concentration-response curve of the effect of Rg 3 on the K ϩ current from the hKv1.4 channel, the peak amplitudes at different concentrations of Rg 3 were plotted, and Origin software (Origin, Northampton, MA, U.S.A.) was used to fit the plot to the Hill equation:
, where y is the peak current at a given concentration of Rg 3 , y max is the maximal peak current, IC 50 is the concentration of Rg 3 producing a half-maximal effect, [A] is the concentration of Rg 3 , and nH is the Hill coefficient. All values are presented as meansϮS.E.M. The significance of differences between mean control and treatment values was determined using Student's t-test. pϽ0.05 was considered statistically significant.
RESULTS
Rg 3 Preferentially Inhibits Non-inactivating Rather Than Peak Outward K
ϩ Currents of hKv1.4D D2-61 Channels Using the two-electrode voltage-clamp technique, we recorded wild-type hKv1.4 and hKv1.4D2-61 channel currents from Xenopus oocytes injected with cRNAs encoding wild-type and hKv1.4D2-61 channel proteins, respectively (Figs. 2A, B) . First, to assess the effect of Rg 3 on the current-voltage (I-V) relationship, we constructed I-V curves with and without Rg 3 in the bath. The current responses evoked by voltage steps (i.e., a series of voltage pulses of 500-ms duration given in 10-mV increments and 10-s intervals from the holding potential of Ϫ80 mV) were used to construct the I-V curve. In wild-type channels, the currents evoked by this voltage-clamp protocol were transient A-type K ϩ currents that rapidly inactivated, i.e., N-type inactivation (Fig. 2C, Con) , 8) whereas in hKv1.4D2-61 channels, the currents evoked by this voltage-clamp protocol were non-inactivating and were long lasting K ϩ currents, indicating that Ntype inactivation is clearly removed as shown in previous reports (Fig. 2D, Con) . 5, 9) In the absence of Rg 3 , both hKv1.4 and hKv1.4D2-61 channel currents were elicited by voltage pulses more positive than Ϫ40 mV, and current amplitude increased linearly with further depolarization (Figs. 2E, F; * pϽ0.05 * * pϽ0.01 at ϩ60 mV, nϭ7-8). As shown in our previous report, 6) in wild-type the presence of Rg 3 (100 mM) reduced the peak current amplitude over the entire voltage range, in which the current was activated (Fig. 2E) , whereas in hKv1.4D2-61 channels, the presence of Rg 3 preferentially reduced non-inactivating plateau rather than peak currents by about 2-fold (Fig. 2E) . The Rg 3 effect on peak and non-inactivating plateau currents was concentration-dependent ( Fig.  3A) and reversible (data not shown). The IC 50 values on peak and non-inactivating plateau currents were 55.8Ϯ4.2 and 41.2Ϯ3.8 mM, respectively (Fig. 3C) . Hill coefficients were 1.4Ϯ0.2 and 1.3Ϯ0.1, respectively. The V max values on peak and non-inactivating plateau currents were 42.3Ϯ2.2 and 69.7Ϯ1.2 mM, respectively (Fig. 3C) . These results indicate that Rg 3 exerts its effect more on non-inactivating currents than peak currents in the regulation of hKv1.4D2-61 channels. Channel Since hKv1.4D2-61 channels, in which amino acid residues 2-61 are deleted to remove N-type inactivation, only exhibit C-type inactivation, 4, 10, 11) we examined the effects of Rg 3 on C-type inactivation in hKv1.4D2-61 channels. As shown in Fig. 3D , the rate of C-type inactivation was increased in a concentration-dependent manner when the channel was exposed to different concentration of Rg 3 . Thus, the percentage of inactivation at 1.5 s from the normalized peak current was 26 ] o from 3 to 99 mM gradually attenuated Rg 3 -mediated changes on the time constant of inactivation. We could observe that Rg 3 had no effect on the inactivation rate in K531Y hKv1.4D2-61 channels (data not shown). We could also observe that Rg 3 had no effect on N-type inactivation in wild-type hKv1.4 channels (data not shown). These results indicate that Rg 3 affects C-type inactivation in hKv1.4D2-61 channels through interaction with K531 residue.
DISCUSSION
The Kv1.4 channel is a transient A-type or rapidly inactivating Kv channel. Kv1.4 channels are mainly located at axon and pre-synaptic terminals, [12] [13] [14] [15] and they function to modulate action potential waveforms and neurotransmitter release. 16, 17) They also affect the amplitude of the plateau phase and duration of action potentials in ventricular myocytes. 2, 18) Thus, these channels are one of the targets of drugs for treatment of pathologic conditions including cardiac arrhythmia. We previously demonstrated that Rg 3 regulates hKv1.4 channel currents through interaction with amino acids including Lys531 residue at channel pore entry.
6) However, very little was known about how Rg 3 affects hKv1.4D2-61 channel activities that show non-inactivating currents and C-type inactivation.
In the present study, we could observe that N-terminal deletion of 2-61 amino acid residues from that of hKv1.4 channel converts transient to non-inactivating outward K ϩ currents (Fig. 2D) . 5) Treatment of Rg 3 to hKv1.4D2-61 channels produced larger inhibitions of non-inactivating plateau than peak outward K ϩ currents in a concentration-dependent manner. Mutation of K531 hKv1.4D2-61 to K531Y hKv1.4D2-61 and raising extracellular [K ϩ ] o abolished Rg 3 -mediated inhibitions of non-inactivating plateau outward K ϩ currents (Figs. 3C, 4B ). In addition, treatment of Rg 3 to hKv1.4D2-61 channels produced an increase of C-type inactivation rate by decreasing inactivation time constants (Fig.  3D ), but the Rg 3 -mediated increase of C-type inactivation rate was attenuated in a extracellular [K ϩ ] o -dependent manner (Figs. 4A, C) .
In the present study, when we deleted N-terminal domain (D2-61) of Kv1.4 channels, we could obtain non-inactivating plateau currents instead of transient currents as shown in wild-type. These results are consistent with the previous "ball and chain" model, which was originally proposed for Na ϩ channel inactivation 19) and for the explanation of the rapid inactivation of a Drosophila Shaker K ϩ channel. 20, 21) Interestingly, the presence of Rg 3 caused more reductions of the non-inactivating plateau portion of currents than peak portion currents, of which the phenomena could not be distinguished in wild-type Kv1.4 channels. These results show a possibility that Rg 3 blocks a prolonged channel opening in hKv1.4D2-61 channels. Similarly, we have shown in our previous report that Rg 3 inhibits inward peak Na ϩ currents of wild-type Nav1.2 channels. Mutation of inactivation gate IlePhe-Met (IFM) to IFMQ3 produced non-inactivating inward currents as observed in Kv1.4 channels in the present study, and the presence of Rg 3 also caused more reductions of the non-inactivating plateau Na ϩ than peak inward Na ϩ currents. 7) In addition, we demonstrated that mutation of Val291 to V291A, which is in transmembrane domain 2 and forms a part of channel gating pore region, in 5-HT 3A receptors induces constitutively active inward currents even in the absence of 5-HT. Rg 3 also inhibits the constitutively active inward currents. 22) These results show a possibility that Rg 3 acts as an open channel blocker of some subsets of ion channels and receptors.
What is the possible mechanism underlying Rg 3 -induced inhibition of non-inactivating hKv1.4D2-61 channel currents? We previously demonstrated that Rg 3 regulates ion channels at the extracellular but not intracellular side using the out-side out patch clamp method. 23) We also showed that modifications or removal of the carbohydrate portion of Rg 3 abolished Rg 3 -mediated ion channel regulations. 24) In addition, our docked modeling study also revealed that the triterpenoid backbone of Rg 3 blocks the channel outer pore when hydrogen bonds between carbohydrate portions of Rg 3 and the channel outer pore are formed. 6) Thus, Rg 3 -induced blockage of the channel outer pore may be a main cause of Rg 3 -induced inhibition of non-inactivating outward K ϩ currents following depolarization. Future studies will be necessary to determine the exact roles of the triterpenoid backbone structures of Rg 3 in terms of non-inactivating Kv1.4D2-61 channel current regulations.
Based on our findings, it seems reasonable to speculate as to whether the in vitro Rg 3 -induced increase in the C-type inactivation rate of Kv1.4 channel in cardiovascular systems could translate to its in vivo pharmacological effects. Ginseng has many beneficial effects on the cardiovascular systems. 25) Ginsenoside administration via the intravenous route attenuates ischemic and reperfused arrhythmia in rats. 26) Ginsenoside administration via the intraperitoneal route attenuates myocardial reperfusion arrhythmia in rats fed a high cholesterol diet. 27) Anti-arrhythmic agent such as quinidine regulates on ferret Kv1.4D2-146 and rat Kv1.4D3-25 channels 28, 29) but we do not have any direct evidence that Rg 3 -mediated Kv1.4D2-146 channel regulations can be used prophylactically or therapeutically against arrhythmia as quinidine can. More investigations are needed of the potential application of Rg 3 to heart dysfunctions.
In summary, we have used N-terminal deletion experiments to further characterize Rg 3 regulation of hKv1.4 channel activity. We found that Rg 3 inhibits the non-inactivating hKv1.4D2-61 channel currents and increases the C-type inactivation rate. However, this regulatory effect of Rg 3 on hKv1.4D2-61 was abolished by the mutation of K531 to K531Y and by raising extracellular [K ϩ ] o . These novel findings provide an insight into ginseng pharmacology at the single cellular and molecular levels.
